BSE filing, NSE: NAVINFLUOR. Summary written from the filing by ALFA Finder's alert engine.
Navin Fluorine International Ltd: key numbers
- Share price
- ₹8,501.00
- Market cap
- ₹43,614 Cr
- Revenue (annual)
- ₹3,314 Cr
- Net profit (annual)
- ₹663.5 Cr
- P/E (TTM)
- 55.2×Sector 34.5×
- Promoter holding
- 27.08%+0.00% QoQ
- FII holding
- 23.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Navin Fluorine International Ltd
All →Navin Fluorine International Employee Stock Options
Navin Fluorine allotted 23,500 equity shares to employees on exercise of options under its ESOP Scheme 2017. No cash consideration or transaction value is stated in the filing.
Navin Fluorine International Other Announcement
Navin Fluorine International Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with Regulation 31(1)(b) of the Listing Regulations.
Navin Fluorine International Production Started
Navin Fluorine's subsidiary, NFASL, has commenced commercial production at its debottlenecked Multi-Purpose Plant at the Dahej site. No new financial value is reported in this update.
Navin Fluorine International Production Started
Navin Fluorine's subsidiary NFASL has commissioned debottlenecking capacity at its Dahej Multi-Purpose Plant. Commercial production and product dispatch commenced today following a ₹75 Crore investment.
- Value
- ₹75.00 Cr
Navin Fluorine International Board Meeting Date
Navin Fluorine International Limited has scheduled a board meeting for October 30, 2026. The board will consider Q2 FY27 financial results and an interim dividend.
Navin Fluorine International Other Announcement
Navin Fluorine disclosed an ESG rating of '64.54 Performer' independently assigned by Niche99. The company clarified it did not engage Niche99; the score is based on public data.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.